Your browser doesn't support javascript.
loading
On-Site Stimulation of Dendritic Cells by Cancer-Derived Extracellular Vesicles on a Core-Shell Nanowire Platform.
Zhang, Min; Ono, Miki; Kawaguchi, Shota; Iida, Mikiko; Chattrairat, Kunanon; Zhu, Zetao; Nagashima, Kazuki; Yanagida, Takeshi; Yamaguchi, Junya; Nishikawa, Hiroyoshi; Natsume, Atsushi; Baba, Yoshinobu; Yasui, Takao.
Afiliação
  • Zhang M; Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.
  • Ono M; Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.
  • Kawaguchi S; Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.
  • Iida M; Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.
  • Chattrairat K; Department of Life Science and Technology, Tokyo Institute of Technology, Nagatsuta 4259, Midori-ku, Yokohama 226-8501, Japan.
  • Zhu Z; Department of Life Science and Technology, Tokyo Institute of Technology, Nagatsuta 4259, Midori-ku, Yokohama 226-8501, Japan.
  • Nagashima K; Research Institute for Electronic Science (RIES), Hokkaido University, Kita, Sapporo, Hokkaido 001-0020, Japan.
  • Yanagida T; Department of Applied Chemistry, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Yamaguchi J; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Nishikawa H; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Natsume A; Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Chiba 277-8577, Japan.
  • Baba Y; Institute of Nano-Life-Systems, Institutes of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.
  • Yasui T; Kawamura Medical Society, Gifu 501-3144, Japan.
ACS Appl Mater Interfaces ; 16(23): 29570-29580, 2024 Jun 12.
Article em En | MEDLINE | ID: mdl-38804616
ABSTRACT
Extracellular vesicles (EVs) contain a subset of proteins, lipids, and nucleic acids that maintain the characteristics of the parent cell. Immunotherapy using EVs has become a focus of research due to their unique features and bioinspired applications in cancer treatment. Unlike conventional immunotherapy using tumor fragments, EVs can be easily obtained from bodily fluids without invasive actions. We previously fabricated nanowire devices that were specialized for EV collection, but they were not suitable for cell culturing. In this study, we fabricated a ZnO/Al2O3 core-shell nanowire platform that could collect more than 60% of the EVs from the cell supernatant. Additionally, we could continue to culture dendritic cells (DCs) on the platform as an artificial lymph node to investigate cell maturation into antigen-presenting cells. Finally, using this platform, we reproduced a series of on-site immune processes that are among the pivotal immune functions of DCs and include such processes as antigen uptake, antigen presentation, and endocytosis of cancer-derived EVs. This platform provides a new ex vivo tool for EV-DC-mediated immunotherapies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Nanofios / Vesículas Extracelulares / Neoplasias Limite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Nanofios / Vesículas Extracelulares / Neoplasias Limite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Ano de publicação: 2024 Tipo de documento: Article